Skip to main content
Services
Technology
Technology
YoctoReactor
Binder Trap Enrichment ®(BTE)
Cellular Binder Trap Enrichment®(cBTE)
Company
Company
Partners
Career
Art
Partners
Partners
Aurigene Pharmaceutical Services
SARomics Biostructures
Boo Kyung S·M Co.
Resources
Resources
Publications
FAQ
Conferences
News
Articles
Posters
Contact
Inquiry
Services
Services
Small molecule drug discovery for even hard-to-drug targets - identify inhibitors, binders and modulators
In living cell
In vitro
Molecular Glue Direct
In living cell
In vitro
PPI Inhibitor Direct
In living cell
In vitro
Integral membrane proteins
In living cell
In vitro
Selectivity Direct – multiplexed screening of target and anti-targets
In living cell
In vitro
Express - optimized for fast turn-around-time
In living cell
In vitro
Snap - easy, fast, and affordable
In living cell
In vitro
Technology
Technology
YoctoReactor
Accelerate molecular discovery with YoctoReactor
®
YR Libraries – advanced automation for efficient screening and optimization.
Read more
Binder Trap Enrichment
Streamline drug discovery with Binder Trap Enrichment
®
– enabling precise and efficient identification of high-affinity binders.
Read more
Cellular Binder Trap Enrichment
Enhance drug discovery with Cellular Binder Trap Enrichment
®
– enabling efficient identification of cellular target binders.
Read more
Partnering with
Vipergen
From straightforward Fee-For-Service to comprehensive joint ventures, we provide flexible partnership structures to align with your project’s distinct needs.
Explore our services
Resources
Articles
DNA-Encoded Libraries
DNA-Encoded Libraries
Medicinal Chemistry Services for DNA-Encoded Library Screening
The Advantages of Using DNA-Encoded Libraries (DELs) in Hit Identification Compared to Traditional High-Throughput Screening (HTS)
DNA-Encoded Libraries vs. Fragment-Based Screening: Pros and Cons
DNA Encoded Libraries: Principle of DNA-Compatible Chemical Reactions for High-Throughput Small Molecule Discovery
Understanding DEL Screening: From Target Binding to Hit Validation
Synthesis of DNA Encoded Libraries for Drug Discovery
Hit Identification & Screening
Hit Identification & Screening
Molecular Display Systems in Drug Discovery: Principles, Platforms, and Applications
From Target to Therapy: A Comprehensive Overview of the Drug Discovery Workflow
High-Throughput Screening in Drug Discovery
Revolutionizing Research with Chemical Libraries
Hit Identification in Drug Discovery
Target Classes
Target Classes
Structural Proteins as Drug Targets
Ion Channels as Drug Targets
Receptors as Drug Targets
Unlocking the Secrets of Kinases in Cellular Regulation
Transcription Factor Inhibitors: From “Undruggable” to Drug Discovery Reality
Protein-Protein Interactions in Disease and Pharmacology: Unlocking New Frontiers in Drug Discovery
Therapeutic Strategies
Therapeutic Strategies
Spatial Pharmacology: Organelle Targeting and Condensate-Mediated Drug Discovery
Next-Generation Targeted Protein Degradation: Beyond Classical PROTACs
Synthetic Lethality and Context-Dependent Cancer Targeting
RNA-Targeted Small Molecules and Translation-Modulating Therapeutics
Autophagy and Lysosome-Based Targeted Degradation Technologies
Choosing the Right Inhibitor Strategy: Antagonists, Agonists, Allosteric & Covalent Inhibitors in Modern Drug Discovery
Xenopus Oocytes in Human Protein Research and Drug Discovery
Small Molecule Drugs: Principles of Drug-Likeness and Molecular Design for Optimal Therapeutic Efficacy
How Molecular Glue is Transforming Drug Discovery
Targeted Protein Degradation
Platforms & Assays
Platforms & Assays
Unlocking the Potential of Cell-Based Assays in Modern Scientific Research
Therapeutic Areas
Therapeutic Areas
CNS Drug Discovery
Cancer Drug Discovery
Company
Get In Touch
Menu
Vipergen ApS
Gammel Kongevej 23A
1
st
floor
1610 Copenhagen
Denmark
VAT: DK28851758
info@vipergen.com
Partnering with
Vipergen
From straightforward Fee-For-Service to comprehensive joint ventures, we provide flexible partnership structures to align with your project’s distinct needs.
Explore our services
Partners
Aurigene Pharmaceutical Services
SARomics Biostructures
Boo Kyung S.M Co.
Company
About us
Team
In brief
Career
Art
Resources
Publications
FAQ
Conferences
News
Articles
Posters
Latest news
Vipergen launches new DEL series with Lib100 and updates Series 50 to Lib058
October 7, 2025
SARomics Biostructures and Vipergen collaborate to offer enhanced drug discovery services
November 11, 2024
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
April 19, 2024
Articles
DNA-Encoded Libraries
Hit Identification & Screening
Target Classes
Therapeutic Strategies
Platforms & Assays
Therapeutic Areas
DNA-Encoded Libraries (DEL)
June 3, 2025
Medicinal Chemistry Services for DNA-Encoded Library Screening
Read more
May 19, 2025
The Advantages of Using DNA-Encoded Libraries (DELs) in Hit Identification Compared to Traditional High-Throughput Screening (HTS)
Read more
May 7, 2025
DNA-Encoded Libraries vs. Fragment-Based Screening: Pros and Cons
Read more
May 5, 2025
DNA Encoded Libraries: Principle of DNA-Compatible Chemical Reactions for High-Throughput Small Molecule Discovery
Read more
May 1, 2025
Understanding DEL Screening: From Target Binding to Hit Validation
Read more
April 15, 2025
Synthesis of DNA Encoded Libraries for Drug Discovery
Read more
Hit Identification & Screening
August 5, 2025
Molecular Display Systems in Drug Discovery: Principles, Platforms, and Applications
Read more
May 7, 2025
From Target to Therapy: A Comprehensive Overview of the Drug Discovery Workflow
Read more
May 1, 2025
High-Throughput Screening in Drug Discovery
Read more
April 15, 2025
Revolutionizing Research with Chemical Libraries
Read more
March 12, 2025
Hit Identification in Drug Discovery
Read more
Target Classes
February 25, 2026
Structural Proteins as Drug Targets
Read more
February 3, 2026
Ion Channels as Drug Targets
Read more
January 21, 2026
Receptors as Drug Targets
Read more
January 7, 2026
Unlocking the Secrets of Kinases in Cellular Regulation
Read more
November 14, 2025
Transcription Factor Inhibitors: From “Undruggable” to Drug Discovery Reality
Read more
June 10, 2025
Protein-Protein Interactions in Disease and Pharmacology: Unlocking New Frontiers in Drug Discovery
Read more
Therapeutic Strategies
March 9, 2026
Spatial Pharmacology: Organelle Targeting and Condensate-Mediated Drug Discovery
Read more
March 9, 2026
Next-Generation Targeted Protein Degradation: Beyond Classical PROTACs
Read more
March 9, 2026
Synthetic Lethality and Context-Dependent Cancer Targeting
Read more
March 9, 2026
RNA-Targeted Small Molecules and Translation-Modulating Therapeutics
Read more
March 9, 2026
Autophagy and Lysosome-Based Targeted Degradation Technologies
Read more
June 18, 2025
Choosing the Right Inhibitor Strategy: Antagonists, Agonists, Allosteric & Covalent Inhibitors in Modern Drug Discovery
Read more
May 7, 2025
Xenopus Oocytes in Human Protein Research and Drug Discovery
Read more
May 5, 2025
Small Molecule Drugs: Principles of Drug-Likeness and Molecular Design for Optimal Therapeutic Efficacy
Read more
March 24, 2025
How Molecular Glue is Transforming Drug Discovery
Read more
January 22, 2025
Targeted Protein Degradation
Read more
Platforms & Assays
August 26, 2025
Unlocking the Potential of Cell-Based Assays in Modern Scientific Research
Read more
Therapeutic Areas
July 11, 2025
CNS Drug Discovery
Read more
July 11, 2025
Cancer Drug Discovery
Read more
